ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
ºñ¸¸´ë»çŬ¸®´Ð
-
[SCIE]
A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension
Song E, Lee YM, Oh HS, Jeon MJ, Song DE, Kim TY, Kim WB, Shong YK, Sung TY, Kim WG
/ A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension
/ 201904
-
[SCI]
Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer
Kun Yang, Minah Cho, Chul Kyu Roh, Won Jun Seo, Seohee Choi, Taeil Son, Hyoung‑Il Kim, Woo Jin Hyung
/ Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer
/ 201903
-
[SCIE]
The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma
Song E, Oh HS, Jeon MJ, Chung KW, Hong SJ, Ryu JS, Baek JH, Lee JH, Kim WG, Kim WB, Shong YK, Kim TY
/ The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma
/ 201903
-
[SCIE]
Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
Song E, Ahn J, Oh HS, Jeon MJ, Kim WG, Kim WB, Shong YK, Baek JH, Lee JH, Ryu JS, Chung KW, Hong SJ, Kim TY
/ Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
/ 201902
-
[SCI]
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
Chul Kyu Roh, Yoon Young Choi, Seohee Choi, Won Jun Seo, Minah Cho, Eunji Jang, Taeil Son, Hyoung-Il Kim, Hyeseon Kim, Woo Jin Hyung, Yong-Min Huh, Sung Hoon Noh, Jae-Ho Cheong
/ Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
/ 60(2): 132-139
/ 201902